The SARS-CoV-2 Lambda variant exhibits enhanced infectivity and immune resistance

SARS-CoV-2 Lambda 变异株表现出更强的感染性和免疫抵抗力。

阅读:5
作者:Izumi Kimura ,Yusuke Kosugi ,Jiaqi Wu ,Jiri Zahradnik ,Daichi Yamasoba ,Erika P Butlertanaka ,Yuri L Tanaka ,Keiya Uriu ,Yafei Liu ,Nanami Morizako ,Kotaro Shirakawa ,Yasuhiro Kazuma ,Ryosuke Nomura ,Yoshihito Horisawa ,Kenzo Tokunaga ,Takamasa Ueno ,Akifumi Takaori-Kondo ,Gideon Schreiber ,Hisashi Arase ,Akatsuki Saito ,So Nakagawa ,Kei Sato

Abstract

SARS-CoV-2 Lambda, a variant of interest, has spread in some South American countries; however, its virological features and evolutionary traits remain unclear. In this study, we use pseudoviruses and reveal that the spike protein of the Lambda variant is more infectious than that of other variants due to the T76I and L452Q mutations. The RSYLTPGD246-253N mutation, a unique 7-amino acid deletion in the N-terminal domain of the Lambda spike protein, is responsible for evasion from neutralizing antibodies and further augments antibody-mediated enhancement of infection. Although this mutation generates a nascent N-linked glycosylation site, the additional N-linked glycan is dispensable for the virological property conferred by this mutation. Since the Lambda variant has dominantly spread according to the increasing frequency of the isolates harboring the RSYLTPGD246-253N mutation, our data suggest that the RSYLTPGD246-253N mutation is closely associated with the substantial spread of the Lambda variant in South America.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。